000			01892 a2200565 4500
005			20250517181717.0
264		0	_c20171208
008			201712s 0 0 eng d
022			_a1471-2415
024	7		_a10.1186/s12886-017-0583-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aMashima, Yukihiko
245	0	0	_aVisual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation. _h[electronic resource]
260			_bBMC ophthalmology _cOct 2017
300			_a192 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge of Onset
650	0	4	_aAged
650	0	4	_aAntioxidants _xtherapeutic use
650	0	4	_aAscorbic Acid _xtherapeutic use
650	0	4	_aChild
650	0	4	_aDNA Mutational Analysis
650	0	4	_aDNA, Mitochondrial _xgenetics
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOptic Atrophy, Hereditary, Leber _xdrug therapy
650	0	4	_aPoint Mutation
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPrognosis
650	0	4	_aRecovery of Function _xphysiology
650	0	4	_aRetrospective Studies
650	0	4	_aRiboflavin _xtherapeutic use
650	0	4	_aUbiquinone _xanalogs & derivatives
650	0	4	_aVision Disorders _xdrug therapy
650	0	4	_aVisual Acuity _xphysiology
650	0	4	_aVisual Field Tests
650	0	4	_aVitamin B Complex _xtherapeutic use
650	0	4	_aYoung Adult
700	1		_aKigasawa, Kazuteru
700	1		_aShinoda, Kei
700	1		_aWakakura, Masato
700	1		_aOguchi, Yoshihisa
773	0		_tBMC ophthalmology _gvol. 17 _gno. 1 _gp. 192
856	4	0	_uhttps://doi.org/10.1186/s12886-017-0583-3 _zAvailable from publisher's website
999			_c27699831 _d27699831